JAMA

7 Stories

Researchers See Link Between Abortion Ban, Newborn Deaths

In the law's first year, fatalities rose 13% in Texas and 2% in the nation overall

(Newser) - Researchers said Monday that a jump in infant and newborn deaths in Texas follows from the state's near-total ban on early-pregnancy abortions. The year after the ban was approved, infant deaths in Texas increased almost 13%, from 1,985 in 2021 to 2,240 in 2022, NBC News reports....

Medical Journal Editor Out After Racism Outcry

Howard Bauchner at JAMA says he is 'profoundly disappointed' in himself

(Newser) - The editor-in-chief of the Journal of the American Medical Association announced his resignation Tuesday following an outcry over a tweet and podcast that questioned the existence of structural racism in medicine. Dr. Howard Bauchner had been on leave since March during an investigation of remarks made by deputy editor Dr....

'No Physician Is Racist' Tweet Doesn't Go Over Well

JAMA medical journal's editor has been suspended amid investigation

(Newser) - The top editor at the Journal of the American Medical Association has been sidelined amid outcry from Black physicians over a tweet and podcast on racism, per the AP . "No physician is racist, so how can there be structural racism in health care?” the tweet read in part, promoting...

Fewer Medical Students Considering Primary Care

Shortage of family doctors looms: study

(Newser) - Just 2% of graduating medical students say they plan to work in primary care, forecasting a shortage of doctors who coordinate care and keep costs low, the AP reports. And it’s not just higher pay luring them away: They fear the paperwork and increased workload. Primary-care doctors must “...

Merck Used Ghostwriters to Draft Rosy Vioxx Studies

Company downplayed risks in medical articles on drug found to be a killer

(Newser) - Merck used its own ghostwriters to draft articles minimizing risks of its drug Vioxx, then found medical researchers to lend their names to the research, the Wall Street Journal reports. Merck, which pulled the painkiller from shelves four years ago over heart-attack risks, rejects the claims as "misleading."...

Screening Isn't Slowing Staph: Study
Screening
Isn't Slowing Staph: Study
Mar 12, 2008 11:09 AM CDT

Screening Isn't Slowing Staph: Study

Researchers back more cost-effective, targeted testing to catch superbug

(Newser) - Widespread screening of hospital patients for the drug-resistant staph bacteria MRSA doesn’t appear to reduce the number of infections, a new study finds. Swiss researchers screened more than 10,000 patients for the superbug when they were admitted to the University of Geneva Hospitals. Another 10,000 weren’t...

Breast Cancer Can Come From Dad, Too

Stealth gene at fault in half of inherited cases; better screening urged

(Newser) - Half of congenital breast cancer victims inherit the disease from their fathers, not their mothers, according to a new study. And unless dad has female relatives with the affliction, the responsible gene may go undiscovered. The study in JAMA warns doctors, increasingly screening family trees for cancer, not to overlook...

7 Stories